Paul Meister is Chairman of Arbor Biotechnologies, Inc and co-founder of Liberty Lane Partners, LLC, a private investment company with investment holdings in life science, diagnostic and healthcare-related businesses. National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the American Association for the Advancement of Science, a Fellow of the National Academy of Inventors, and is inducted in the US National Inventors Hall of Fame.
National Academy of Engineering, the U.S. Hach Award for Entrepreneurial Success, the 2016 Ralph Adams Award in Bioanalytical Chemistry, the 2014 American Chemical Society Gustavus John Esselen Award, the 2013 Analytical Chemistry Spectrochemical Analysis Award, the 2013 Pittsburgh Analytical Chemistry Award, and the 2010 ACS National Award for Creative Invention. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules He has received numerous awards and honors, including the 2017 American Chemical Society Kathryn C. David is the Scientific Founder of Illumina Inc., Quanterix Corp., and has co-founded several other life sciences startups. David is co-Director of the Mass General Brigham Center for COVID Innovation.
Walt is the Hansjörg Wyss Professor of Bioinspired Engineering at Harvard Medical School and Professor of Pathology at Harvard Medical School and Brigham and Women’s Hospital, is a Core Faculty Member of the Wyss Institute at Harvard University, Associate Member at the Broad Institute, and is a Howard Hughes Medical Institute Professor. Feng received his AB in Chemistry and Physics from Harvard College and his PhD in Chemistry from Stanford University.ĭavid R. He has also received technology innovation awards from the McKnight, New York Stem Cell, and Damon Runyon foundations. Waterman Award, the Jacob Heskel Gabbay Award in Biotechnology and Medicine, the Society for Neuroscience Young Investigator Award, the Canada Gairdner International Award, and the Tang Prize. Feng is a recipient of many awards including the Perl/UNC Prize in Neuroscience, the NIH Director's Pioneer Award, the National Science Foundation's Alan T. Since joining the Broad and McGovern institutes in January 2011, Feng has pioneered the development of genome editing tools for use in eukaryotic cells - including human cells - from natural microbial CRISPR systems. He played a seminal role in developing optogenetics, a powerful technology for dissecting neural circuits using light. Feng is a bioengineer developing and applying novel molecular technologies for studying the molecular and genetic basis of diseases and providing treatment. Recognition for his research and entrepreneurship has included the Sir Peter Mansfield Research Fellowship, Herchel Smith Undergraduate Research Fellowship, Olken Brothers’ Award for Entrepreneurial Spirit, Harvard I3 Innovation Challenge Winner, Micron Science & Technology Scholarship Top Awardee, and the Paul & Daisy Soros Fellowship.įeng Zhang is a core institute member of the Broad Institute of MIT and Harvard, as well as an investigator at the McGovern Institute for Brain Research at MIT, the James and Patricia Poitras Professor in Neuroscience at MIT. Winston graduated magna cum laude with a BS in Physics from Harvard College, and PhD in Biophysics from Harvard University as a part of the Harvard-MIT MD/PhD program. This included developing smaller orthologs of Cas9 for better packaging into the most therapeutically promising viral vectors for gene therapy, building assays that enhance off-target detection to evaluate the genomic safety of CRISPR-Cas enzymes, and additionally searching for new enzyme systems to power genome engineering capabilities beyond nucleases. Prior to co-founding Arbor, Winston worked in the laboratory of Feng Zhang at MIT and the Broad Institute, where he focused on addressing challenges that limit the in vivo therapeutic applications of CRISPR-Cas nucleases. Winston is a biotechnologist discovering and developing applications for novel molecular technologies.
0 kommentar(er)
